1. Home
  2. ICL vs HALO Comparison

ICL vs HALO Comparison

Compare ICL & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICL
  • HALO
  • Stock Information
  • Founded
  • ICL 1968
  • HALO 1998
  • Country
  • ICL Israel
  • HALO United States
  • Employees
  • ICL N/A
  • HALO N/A
  • Industry
  • ICL Agricultural Chemicals
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ICL Industrials
  • HALO Health Care
  • Exchange
  • ICL Nasdaq
  • HALO Nasdaq
  • Market Cap
  • ICL 8.1B
  • HALO 7.4B
  • IPO Year
  • ICL N/A
  • HALO N/A
  • Fundamental
  • Price
  • ICL $6.81
  • HALO $47.91
  • Analyst Decision
  • ICL Hold
  • HALO Buy
  • Analyst Count
  • ICL 2
  • HALO 9
  • Target Price
  • ICL $6.75
  • HALO $63.56
  • AVG Volume (30 Days)
  • ICL 672.9K
  • HALO 3.0M
  • Earning Date
  • ICL 05-19-2025
  • HALO 05-06-2025
  • Dividend Yield
  • ICL 2.76%
  • HALO N/A
  • EPS Growth
  • ICL N/A
  • HALO 55.40
  • EPS
  • ICL 0.32
  • HALO 3.76
  • Revenue
  • ICL $6,841,000,000.00
  • HALO $1,084,306,000.00
  • Revenue This Year
  • ICL $4.71
  • HALO $24.79
  • Revenue Next Year
  • ICL $4.08
  • HALO $22.65
  • P/E Ratio
  • ICL $21.65
  • HALO $13.36
  • Revenue Growth
  • ICL N/A
  • HALO 25.64
  • 52 Week Low
  • ICL $3.79
  • HALO $41.28
  • 52 Week High
  • ICL $6.84
  • HALO $70.51
  • Technical
  • Relative Strength Index (RSI)
  • ICL 64.68
  • HALO 32.31
  • Support Level
  • ICL $6.68
  • HALO $58.38
  • Resistance Level
  • ICL $6.95
  • HALO $69.94
  • Average True Range (ATR)
  • ICL 0.12
  • HALO 3.37
  • MACD
  • ICL -0.01
  • HALO -1.11
  • Stochastic Oscillator
  • ICL 66.67
  • HALO 1.78

About ICL ICL Group Ltd.

ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and growing solutions. These segments all contribute to the company's development of agriculture, food, and engineered material products and services. The company mines and manufactures potash and phosphates to be used as ingredients in fertilizers and serve as a component in the pharmaceutical and food additives industries. It is also engaged in industrial additives and materials, including flame retardants, phosphate salts, specialty phosphate blends, purified phosphoric acid, electronic-grade specialty phosphoric acids. Its geographical segments are Europe, Asia, North and South America, and the Rest of the world.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: